S489 50 mg Pill - blue & white capsule/oblong, 16mm
Generic Name: lisdexamfetamine
Pill with imprint S489 50 mg is Blue & White, Capsule/Oblong and has been identified as Vyvanse 50 mg. It is supplied by Shire US Inc.
Vyvanse is used in the treatment of Binge Eating Disorder; ADHD and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Vyvanse 50 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for S489 50 mg
Vyvanse
- Generic Name
- lisdexamfetamine
- Imprint
- S489 50 mg
- Strength
- 50 mg
- Color
- Blue & White
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Shire US Inc.
- National Drug Code (NDC)
- 59417-0105
See also:
Adderall
Adderall (amphetamine and dextroamphetamine) is used to treat narcolepsy and ADHD. Includes side ...
Strattera
Strattera (atomoxetine) is used to treat attention deficit hyperactivity disorder. Learn about side ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Concerta
Concerta is used to treat attention deficit disorder (ADD) and attention deficit hyperactivity ...
Ritalin
Ritalin (methylphenidate) is used to treat attention deficit disorder (ADD) and narcolepsy ...
Focalin
Focalin (dexmethylphenidate) is used to treat attention deficit hyperactivity disorder (ADHD) ...
Jornay PM
Jornay PM is a delayed- and extended-release capsule formulation containing the CNS stimulation ...
More about Vyvanse (lisdexamfetamine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (975)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- Support group
- FDA approval history
- Drug class: CNS stimulants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.